Literature DB >> 3494251

The cytolytic protein of human lymphocytes related to the ninth component (C9) of human complement: isolation from anti-CD3-activated peripheral blood mononuclear cells.

L S Zalman, D E Martin, G Jung, H J Müller-Eberhard.   

Abstract

A 70-kDa channel-forming protein has recently been isolated from human large granular lymphocytes maintained in interleukin-2-dependent culture. The protein was shown to be immunochemically related to the ninth component of complement (C9) and was therefore designated C9-related protein (C9RP). Using the procedure that was developed for the isolation of C9RP from large granular lymphocytes--i.e., affinity chromatography employing anti-human C9 linked to Sepharose, a cytolytic protein has now been isolated from OKT3-activated human peripheral blood mononuclear cells. Nineteen to 40 micrograms of active protein was obtained from 1 X 10(9) human peripheral blood mononuclear cells after the cells were cultured for 3 days with OKT3 (monoclonal antibody to cell surface antigen T3). During this period, a marked increment occurred in the amount of the cytotoxic protein contained per cell, indicating that OKT3 induced de novo synthesis of the protein. By NaDodSO4/PAGE the molecular mass was determined to be 70 kDa. By ELISA the isolated protein and C9RP of large granular lymphocytes reacted to the same extent with anti-C9RP. Using K-562 or M21 human melanoma cells as targets, the cytotoxic activity of the isolated protein, in the presence of 5 mM Ca2+, was comparable to that of C9RP. The same cytolytic protein was isolated from peripheral blood mononuclear cells that were depleted of CD16+ cells prior to OKT3 activation and that consisted primarily of CD4+ and CD8+ T lymphocytes. These results suggest that the cytolytic protein of OKT3-activated cytotoxic T lymphocytes is identical with C9RP of interleukin-2-stimulated large granular lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494251      PMCID: PMC304664          DOI: 10.1073/pnas.84.8.2426

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells.

Authors:  P A Henkart; C C Yue; J Yang; S A Rosenberg
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

3.  Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.

Authors:  R Schwab; M K Crow; C Russo; M E Weksler
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

Review 4.  Mechanism of lymphocyte-mediated cytotoxicity.

Authors:  P A Henkart
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

5.  Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody.

Authors:  P Perez; R W Hoffman; S Shaw; J A Bluestone; D M Segal
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

6.  Interleukin 2 dependence of human natural killer (NK) cell activity.

Authors:  W Domzig; B M Stadler; R B Herberman
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes.

Authors:  D Masson; J Tschopp
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

8.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

Authors:  L L Lanier; A M Le; J H Phillips; N L Warner; G F Babcock
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

9.  Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.

Authors:  C D Tsoukas; B Landgraf; J Bentin; M Valentine; M Lotz; J H Vaughan; D A Carson
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells.

Authors:  B Manger; A Weiss; C Weyand; J Goronzy; J D Stobo
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

View more
  8 in total

1.  Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.

Authors:  E Berti; D Tomasini; M H Vermeer; C J Meijer; E Alessi; R Willemze
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

3.  Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.

Authors:  D E Martin; L S Zalman; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.

Authors:  G Jung; J A Ledbetter; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.

Authors:  L S Zalman; M A Brothers; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.

Authors:  D E Martin; L S Zalman; G Jung; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes.

Authors:  L S Zalman; L M Wood; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

8.  Augmentation by bispecific F(ab')2 reactive with P-glycoprotein and CD3 of cytotoxicity of human effector cells on P-glycoprotein positive human renal cancer cells.

Authors:  Y Heike; K Okumura; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1992-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.